机译:在治疗意图手术或放射治疗(ProCsma研究)之前将镓-68前列腺特异性膜抗原(PSMA)PET成像对临床高危前列腺癌进行临床的前瞻性随机的多期式研究。临床试验方案
Genitourinary Oncology Tumour Multidisciplinary TeamCancer Surgery and Radiation OncologyMelbourne;
Genitourinary Oncology Tumour Multidisciplinary TeamCancer Surgery and Radiation OncologyMelbourne;
Genitourinary Oncology Tumour Multidisciplinary TeamCancer Surgery and Radiation OncologyMelbourne;
Genitourinary Oncology Tumour Multidisciplinary TeamCancer Surgery and Radiation OncologyMelbourne;
Centre for Biostatistics and Clinical Trials (BaCT)Peter MacCallum Cancer CentreMelbourne Vic;
Centre for Health Economics Research and EvaluationUniversity of Technology SydneySydney NSW;
Nuclear MedicineRoyal North Shore HospitalSt Leonards NSW Australia;
Medical PhysicsPeter MacCallum Cancer CentreMelbourne Vic. Australia;
Genitourinary Oncology Tumour Multidisciplinary TeamCancer Surgery and Radiation OncologyMelbourne;
Nuclear MedicinePerth Australia;
Genitourinary Oncology Tumour Multidisciplinary TeamCancer Surgery and Radiation OncologyMelbourne;
prostate cancer; staging; decision impact; PSMA PET; randomized study;
机译:在治疗意图手术或放射治疗(ProCsma研究)之前将镓-68前列腺特异性膜抗原(PSMA)PET成像对临床高危前列腺癌进行临床的前瞻性随机的多期式研究。临床试验方案
机译:主要临床试验的议定书,预期,多期,镓-68前列腺特异性膜抗原正电子扫描/计算机断层扫描的诊断价值诊断值的横截面研究,在正在调查的男性诊断环境中为多游幂磁共振成像 对于前列腺癌
机译:GA-68-前列腺特异性膜抗原(PSMA)正电子发射断层扫描/计算断层扫描(PET / CT)在治疗前列腺特异性抗原患者中的临床影响:治疗术后疗效术后:多学科方法的初步分析
机译:影像学前列腺癌:光学和放射性前列腺特异性膜抗原(PSMA)抑制剂的设计,合成和生物学评估
机译:68G标记前列腺特异性膜抗原正电子发射断层扫描/计算机断层扫描和磁共振成像对根治性前列腺切除术中高危前列腺癌的诊断性能:系统评价和荟萃分析
机译:68gallium标记的前列腺特异性膜抗原正电子发射断层扫描/计算断层扫描和磁共振成像的诊断性能,用于在自由基前列腺切除术前与中间或高风险分期前列腺癌:系统评价和荟萃分析
机译:前列腺特异性膜抗原(psma)作为靶向治疗前列腺癌对肽前药的酶促活化